ArticlePloS one2025
Prevalence of gastroesophageal reflux disease and its associated risk factors among the adult population of Mthatha, Eastern Cape, South Africa.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epidemiological data on gastroesophageal reflux disease (GERD) reveal variations in prevalence rates and risk factors, which are still to be elucidated in the South African setting. Population-specific data are needed to contribute to the understanding of the pathophysiology of GERD. This study aims to determine GERD's prevalence and associated risk factors among Mthatha residents. A descriptive cross-sectional study was carried out with a systematically sampled 353 adults attending the outpatient department of a secondary health care facility using the standardized GERD questionnaire (GerdQ) for screening and diagnosis. Descriptive and inferential statistics were performed with the aid of SPSS version 26. The prevalence of GERD was 32.0 percent (CI: 27.3% to 37.0%). Only 6.5 percent had an 89% likelihood of having GERD. Over half (53.1%) had GERD with little effect on day-to-day activities. The most common symptoms were heartburn at 49.6 percent, sleep disturbance at 34.8 percent, chest pain at 32.3 percent, and regurgitation at 32.3 percent, and were mild in most of them. Hypertension (OR = 3.0, CI: 1.5-6.4, p = 0.003) and eating more than three meals a day (OR = 4.2, CI: 1.9-9.2, p < 0.0001) were the major risk factors for GERD. The GERD rate of one in every three people is higher than the global rate of one in every six. The association of GERD with hypertension requires consideration of screening for GERD in patients with hypertension. Community education on proper dietary habits and the consequences of excess daily meals is needed to interrupt the development of GERD in the current population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.